Object Pharma specializes in innovative neurotoxin therapy to transform depression treatment. Focusing on clinically unique and effective solutions, the company aims to provide safe alternatives that reduce reliance on traditional antidepressants, fostering advancements in mental health care globally.
Specialties
Neurotoxin Therapy
Innovative Depression Treatment
Clinically Unique Solutions
Minimizing Antidepressant Reliance
Global Mental Health Advancements
Products & Services
Neurotoxin Therapy
Depression Treatment Solutions
Mental Health Innovations
Safe Antidepressant Alternatives
Therapeutic Approaches
Contact Information
No contact information available
Competitors & Similar Companies(9)
Neurocrine Biosciences
California, • United States
Jonah Ventures
Axovant Gene Therapies
Basel-City, • Switzerland
Acorda Therapeutics
New York, • United States
Sage Therapeutics
Massachusetts, • United States
Zynerba Pharmaceuticals
Pennsylvania, • United States
Ampio Pharmaceuticals
Colorado, • United States
Cerecor Inc.
Maryland, • United States
Relmada Therapeutics
New York, • United States • Pharmaceuticals
News & Media
Search Terms:
object
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Object Pharma specializes in innovative neurotoxin therapy to transform depression treatment. Focusing on clinically unique and effective solutions, the company aims to provide safe alternatives that reduce reliance on traditional antidepressants, fostering advancements in mental health care globally.